Lunit develops AI-powered medical image analysis software via cutting-edge deep learning technology. Our systems can help physicians make accurate and efficient clinical decisions through data-driven imaging biomarkers. Lunit SCOPE IO enables AI-powered immune phenotyping, purely from H&E slide images. Patients with the immune-excluded phenotype can be reliably identified using Lunit SCOPE IO, and SCOPE IO has been used in Phase 1/2 clinical trials of TGF-β inhibition therapy to successfully enrich for responders. SCOPE IO can be accessed globally for both exploratory and clinical use.
Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. Aragen offers end-to-end integrated or standalone solutions to advance small and large molecule programs from concept to commercialization. Established in 2001, the Company operates through a global network of six sites with a team of 3800+ employees and 450+ PhDs. Its expertise and experience have enabled over 450 customers (including 7 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, a clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.
Beacon Targeted Therapies
We are a competitive and research intelligence database solution designed in partnership with pharmaceutical professionals across the world. We work in targeted therapies such as targeted protein degradation to provide accurate, in-depth, and real-time information in the rapidly evolving landscape of drug development. Find out how Beacon Targeted Therapies can accelerate your drug development program by visiting our website: